Статья

Pandemic COVID-19: Features of the mechanism of drug action

E. Kareva, V. Bulgakova, S. Serebrova, N. Pshenichnaya, O. Oleinikova, A. Poromov, E. Volchkova, V. Fisenko,
2021

Main drugs used to treat COVID-19 and its complications are reviewed. Brief information about the molecular mechanisms of action of etiotropic, pathogenetic and symptomatic palliative drugs is given. A comparative analysis of data available on the efficacy and safety of drugs and the risks of drug interactions is carried out. There are currently no proven effective treatments for COVID-19. Rapidly expanding knowledge about the nature of SARS-CoV-2 is creating conditions for increase in the number of potential drug targets for the treatment of COVID-19.

Цитирование

Похожие публикации

Документы

Источник

Версии

  • 1. Version of Record от 2021-01-01

Метаданные

Об авторах
  • E. Kareva
    Sechenov First Moscow State Medical University, Pirogov Russian National Research Medical University (RNRMU)
  • V. Bulgakova
    Pirogov Russian National Research Medical University (RNRMU), Russian Academy of Sciences
  • S. Serebrova
    Sechenov First Moscow State Medical University, Ministry of Health of Russian Federation
  • N. Pshenichnaya
    Ministry of Health of Russian Federation
  • O. Oleinikova
    Pirogov Russian National Research Medical University (RNRMU)
  • A. Poromov
    I. I. Mechnikov Research Institute for Vaccines and Sera RAMS
  • E. Volchkova
    Sechenov First Moscow State Medical University
  • V. Fisenko
    Sechenov First Moscow State Medical University
Название журнала
  • Eksperimental'naya i Klinicheskaya Farmakologiya
Том
  • 84
Выпуск
  • 3
Страницы
  • 28-40
Номер гранта
  • undefined
Тип документа
  • journal article
Тип лицензии Creative Commons
  • CC BY
Правовой статус документа
  • Свободная лицензия
Источник
  • scopus